These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28346212)

  • 21. Stability of captopril in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):336-8. PubMed ID: 24261148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of an extemporaneously prepared tadalafil suspension.
    Pettit RS; Johnson CE; Caruthers RL
    Am J Health Syst Pharm; 2012 Apr; 69(7):592-4. PubMed ID: 22441791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1998 Sep; 55(18):1915-20. PubMed ID: 9784772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temozolomide stability in extemporaneously compounded oral suspensions.
    Trissel LA; Zhang Y; Koontz SE
    Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
    Stanisz BJ; Paszun SK; Zalewska A
    Acta Pol Pharm; 2014; 71(4):661-6. PubMed ID: 25272892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children.
    Pramann LA; Davidow LW; van Haandel L; Funk RS
    Int J Pharm Compd; 2016; 20(3):257-261. PubMed ID: 28333668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of flecainide acetate in an extemporaneously compounded oral suspension.
    Wiest DB; Garner SS; Pagacz LR; Zeigler V
    Am J Hosp Pharm; 1992 Jun; 49(6):1467-70. PubMed ID: 1529992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of a pyrimethamine suspension compounded from bulk powder.
    Lewis PO; Cluck DB; Huffman JD; Ogle AP; Brown SD
    Am J Health Syst Pharm; 2017 Dec; 74(24):2060-2064. PubMed ID: 29222363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of sotalol in two liquid formulations at two temperatures.
    Nahata MC; Morosco RS
    Ann Pharmacother; 2003 Apr; 37(4):506-9. PubMed ID: 12659604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of two stable oral suspensions for gabapentin.
    Nahata MC
    Pediatr Neurol; 1999 Mar; 20(3):195-7. PubMed ID: 10207927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of sumatriptan succinate in extemporaneously prepared oral liquids.
    Fish DN; Beall HD; Goodwin SD; Fox JL
    Am J Health Syst Pharm; 1997 Jul; 54(14):1619-22. PubMed ID: 9248606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution.
    Tannous E; Tal Y; Amarny K
    Int J Pharm Compd; 2016; 20(5):438-439. PubMed ID: 28339380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of an extemporaneously prepared thalidomide suspension.
    Kraft S; Johnson CE; Tyler RP
    Am J Health Syst Pharm; 2012 Jan; 69(1):56-8. PubMed ID: 22180553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of nifedipine in two oral suspensions stored at two temperatures.
    Nahata MC; Morosco RS; Willhite EA
    J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
    Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
    Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of levetiracetam in extemporaneously compounded suspensions.
    Ensom MH; Decarie D; Rudolph S
    Can J Hosp Pharm; 2011 May; 64(3):207-11. PubMed ID: 22479056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1998 Sep; 55(17):1804-9. PubMed ID: 9775343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.